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Abstract It is not clear how the increase in intraluminal
pressure behind an obstructing ureteric calculus causes an
increase in action potential frequency in ureteric sensory
nerves so the pain messages are transmitted to the brain. It
has been proposed that ureteric distension causes urothelial
release of ATP, which activates purinoceptors on subur-
othelial nociceptive sensory nerves. The purpose of this
study was to determine whether distension of the human
ureter results in the release of ATP and whether the
nociceptive P2 receptor, P2X3, is expressed on suburothe-
lial sensory nerves in the human ureter. Human ureter
segments were perfused with Krebs solution and intermit-
tently distended to a range of pressures. Samples of
perfusate were collected throughout and the ATP concen-
tration ([ATP]) was determined using a luciferin-luciferase
assay. Sections of ureter were stained using antibodies
against P2X3 and capsaicin receptors (TRPV1). [ATP] rose
to more than 10 times baseline levels after distension
beyond a threshold of 25–30 cmH2O. Immunofluorescence
studies on consecutive frozen sections showed that sub-
urothelial nerves stained positively for P2X3 and capsaicin
receptors, with no staining in controls. These findings are
consistent with the hypothesis that purinergic signalling is
involved in human ureteric mechanosensory transduction,
leading to nociception.
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Abbreviations
ABC avidin-biotin complex technique
FITC fluorescein isothiocyanate
NHS normal horse serum
PBS phosphate-buffered saline
TRPV1 transient receptor potential vanilloid 1
Introduction
Pain due to a calculus causing an acute obstruction in the
ureter can be severe and treatment with non-steroidal anti-
inflammatory drugs or opiate analgesia does not always
result in adequate pain relief. Human studies have shown
that, following obstruction, continued urine production
gradually increases the intraluminal pressure behind the
blockage. The onset of pain occurs once the pressure
reaches a mean threshold of 33 mmHg [1]. The pressure
rise results in distension of the proximal ureter and renal
pelvis, but it is not clear how this leads to neuronal activity
so that pain messages might be transmitted to the brain.
Local inflammation caused by the calculus releases inflam-
matory mediators, such as bradykinin or neurokinin A,
which may sensitise afferent neurons via specific receptors
[2–4]. However, the clear on-off link between pressure and
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human studies strongly indicate that the release of inflam-
matory mediators is not the principal mechanosensory
transduction mechanism [1, 5]. There is a rich plexus of
suburothelial afferent nerves in the ureter [6], and the
afferent pathways from here via the splanchnic plexi, lower
lumbar dorsal nerve roots and spinothalamic tracts have
been well documented and studied [5, 7].
Burnstock [8] proposed that in tubes (e.g. ureter, salivary
duct, bile duct, vagina and intestine) and in sacs (e.g.
urinary bladder, gall bladder and lung) nociceptive mecha-
nosensory transduction occurs where distension releases
ATP from the epithelial cells lining these organs, which
then activates P2X3 and/or P2X2/3 receptors on subepithe-
lial sensory nerve plexuses to relay messages to the central
nervous system pain centres. Evidence to support the
mechanosensory role of ATP was first shown in the bladder
[9, 10]. P2X3 receptor immunoreactivity has been found on
nerves in the suburothelial plexus in the rat bladder [11].
Increased electrical activity was recorded in the afferent
pelvic nerves of rats during slow distension of the bladder,
and this activity was inhibited by desensitising the P2X3
receptors with α,β-meATP and also by receptor antagonism
with suramin [12]. There was also reduced sensory nerve
activity in P2X3 receptor-deficient mice [13]. ATP was
shown to be released during distension of the mouse
bladder, proportionate to the degree of distension and
corresponding to the activity of multi-fibre pelvic nerve
afferents [14].
In a later study, it was shown that distension of the
guinea-pig ureter increased spike discharge in sensory
neurons, which was mimicked by ATP and reduced by
ATP antagonists [15]. Knight et al. [16] found that dis-
tending the guinea-pig ureter caused a pressure-dependent
release of ATP, approximately 10 times the basal release
levels. Lee et al. [11] demonstrated P2X3 receptor im-
munoreactivity in the nerves in the suburothelial plexus in
rats.
In the present study, experiments have been carried out
to investigate whether ATP is released from the human
ureter upon distension and whether human ureteric sub-
urothelial sensory nerves express P2X3 receptors.
Materials and methods
Tissue
Following ethical approval and consent, 3-cm segments of
ureter (of the proximal or mid third; the orientation being
marked by a tread) were taken from patients undergoing
radical nephrectomy for renal cell carcinoma, the sample as
far from the kidney to be considered ‘normal’ tissue. The
ureteric segments (which all appeared healthy and non-
distended) were each cut into a 1-cm and a 2-cm length.
The 1-cm segments were mounted on labelled cork squares
in OCT embedding compound (BDH Laboratory supplies,
Poole, UK) and frozen in isopentane pre-cooled in liquid
nitrogen. lmmunohistochemical analysis was subsequently
performed on these samples as described below. The
remaining segments were orientated for use in the ATP
release experiments so that perfusion was in the direction of
peristalsis.
Immunofluorescence
Immunofluorescence was performed using antibodies
against the P2X3 receptor and the capsaicin receptor (also
known as the transient receptor potential vanilloid 1-
TRPV1) on adjacent sections. Negative controls were
performed in the absence of primary antibody and also
with pre-adsorption of primary antibody with nascent
peptide.
Tissues were sectioned at 12 μm on a cryostat (Reichert
Jung CM1800) and collected on gelatin-coated slides and
air-dried at room temperature for 30 min. For amplification
a primary and secondary antibody with an avidin-biotin
complex technique (ABC) was used as follows: the sections
were fixed in 4% buffered formaldehyde for 2 min and then
washed three times (each for 5 min) in phosphate-buffered
saline (PBS). The sections were then incubated for 20 min
at room temperature in 10% normal horse serum (NHS) in
PBS + 0.05% merthiolate (Sigma Chemical Co., Poole,
UK). Following this, sections were incubated overnight in
primary antibody diluted 1:200 in 10% NHS in PBS +
merthiolate. Incubation was performed in moisturised air-
tight incubation chambers at room temperature. Incubation
was also tried at 4°C for 3 days, with differing NaCl levels
in the diluents, and with altered concentrations of primary
antibody, but binding was not found to be more specific.
The following day the sections were initially washed three
times in PBS. They were then incubated for 1 h at room
temperature in biotinylated donkey anti-rabbit immunoglo-
bin (Jackson Immunoresearch Laboratories, Luton, UK).
This was diluted 1:500 in 1% NHS in PBS and merthiolate.
Following three further washes in PBS the sections were
incubated in streptavidin FITC (fluorescein isothiocyanate;
Jackson Immunoresearch Laboratories, Luton, UK) diluted
1:200 in PBS and merthiolate. This was performed at room
temperature in the dark. The sections were then mounted
under coverslips in a glycerol mountant (Citifluor Ltd,
London, UK) and viewed using a Zeiss Axioplan (Ober-
kochen, Germany) microscope with a dark field linked to a
Leica DC200 digital camera (Heerbrugg, Switzerland). A
primary antibody against P2X3 receptors was used. The
antibody was obtained through collaboration with Roche
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to methods described by Lee et al. [11]. Controls were
performed on adjacent ureteric sections by omitting the
primary antibody and also by pre-adsorbing the P2X3
antibody with its cognate peptide.
A significant amount of autofluorescence originated from
the collagen fibres in the sections. This was dampened by a 5-
min incubation of all sections in pontamine sky blue before
mounting in glycerol mountant (Citifluor Ltd, London, UK).
The sections were viewed in a Zeiss Axioplan microscope
using a dark field linked to a Leica DC200 digital camera.
Measurement of ATP release from the human ureter during
distension
The 2-cm ureteric segments were catheterised at each
end with a 6 French paediatric feeding tube and securely
tied with 5/0 silk. They were placed in a Petri dish
embedded with dental wax, into which non-corrodible
metal staples had been previously positioned to keep the
ureters straight and prevent excessive movement. The Petri
dish was filled with Krebs solution, bubbled continuously
with 95% O2 and 5% CO2. All experiments were carried
out at room temperature as in the study by Knight et al. [16]
(and personal communication). The feeding tube at the
proximal end of the ureter was connected via a Luer lock to
a 3-way tap. A diaphragm pressure transducer (model P23
ID, Gould Inc, Oxnard, CA, USA) was connected to one
outlet and to the other (via further tubing) a peristaltic pump
(Watson-Marlow Ltd, Fainmouth, UK). The feeding tube
attached to the distal end of the ureter was cut short to
minimise dead space and allowed to drain into a collecting
container. Pressure was monitored using a Grass polygraph
(model 7D). Pressure readings were calibrated and zeroed
by altering the height of the preparation against a ruler. The
segments were perfused in an isoperistaltic direction at a
constant flow rate of 0.6 ml
-1min with Krebs solution.
Ureters were allowed to equilibrate for at least 45 min with
perfusion before the experiment commenced. The experi-
mental set-up allowed collection of 30-s perfusate aliquots
in 0.5 ml Eppendorf tubes at various points during the
experiments. Distensions were performed by clamping the
feeding tube at the distal end of the ureter with a clip while
continuing the pump flow until the desired pressure was
achieved. The pump was switched off at this point. The
haemostat was released after 1 min, the pump immediately
restarted and the perfusates collected.
After equilibration, three baseline aliquots of perfusate
were collected without distension. Distensions were per-
formed in varying sequences to pressures in the range of 10–
250cmH2O. For each distension 30-s perfusate aliquots were
collected for immediately before distension and at release +
30 s, + 60 s, + 90 s, + 150 s, + 270 s (n=at least 7 for each
distension pressure, from 20 ureters). Distensions were
separated by 12 min. Each sample was sealed in an
Eppendorf tube and immediately frozen to −20°C for
analysis as a batch.
The amount of ATP in the perfusate was quantified using
the luciferin-luciferase assay. The perfusate samples (50 μl
of each) and ATP standards were pipetted into a white, non-
phosphorescent 96-well plate. The plate was placed in a
luminometer (Lucy 1, Anthos Labtec, Salzburg, Austria)
and processed automatically by injection of 100 μlo f
luciferin-luciferase reagent (ATP monitoring reagent, Bio-
Orbit, Turku, Finland) into each well and measured for
10 s. The ATP concentrations ([ATP]) were calculated from
a calibration curve constructed from the ATP standards. The
detection limit was approximately 5 fmol per sample.
Statistical analysis
The concentration of ATP measured in each aliquot was
plotted against time for each series of distensions (n≥7f o r
each distension). The [ATP] in perfusate was also plotted
grouping data into 30 cmH2O pressure ranges. At each
pressure range a Student’s t-test was performed to compare
mean [ATP] in control and following distension. [ATP] in
perfusate following each distension was then plotted against
distension pressure and a best-fit line plotted using linear
regression to test whether the gradient of the line was
significantly different from zero (i.e. whether the ATP release
was pressure dependent). P<0.05 was considered significant.
Results
Immunofluorescence
Nerves bundles were identified running immediately under
the urothelium. These demonstrated immunoreactivity for
both the P2X3 and TRPV1 receptors (Fig. 1a,b). Staining
was absent following pre-adsorption of the anti-P2X3
receptor antibody with nascent peptide. No staining was
seen in the absence of primary antibody (Fig. 1c,d).
ATP release studies
The mean baseline [ATP] was 1.4 + 0.18 nM. Increased
concentrations of ATP were found in the perfusate following
distensionbeyondapressurethresholdof25–30cmH2Oi na l l
ureter specimens. [ATP] rose to more than 10 times the
baseline concentrations on distension. A typical experiment
is demonstrated in Fig. 2, showing ATP concentrations as
sequentially higher distension pressures (NB: The order of
pressures was varied in different ureteric preparations, with a
minimum of n=7 for each pressure).
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before and after distension grouped in pressure ranges. The
mean [ATP] after distension was significantly greater than
before distension in each pressure range (paired Student’s
t-test, P<0.01). Beyond the threshold there was a trend of
increasing [ATP] release with higher pressures, but this
difference was not statistically significant.
Discussion
The immunofluorescence study has shown that nerve
bundles under the urothelium, which expressed TRPV1-
like immunoreactivity (indicating that they are sensory
afferent nerves), also expressed P2X3 receptor immunore-
activity. The specificity of the staining has been confirmed
by the absence of staining in the absence of primary
antibody and also when the primary antibody has been pre-
adsorbed using nascent peptide. These data are consistent
with the findings that P2X3 receptors may be expressed on
nerves in the suburothelial ureter plexus in rats [11].
Release of ATP from guinea-pig ureter during distension
has been described [16]. The present distension experi-
ments have shown that the human ureter also releases ATP
in response to distension, in excess of 10 times the basal
release rate. While ATP is an agonist at both P2X1 receptors
(found on smooth muscle) and P2X3 receptors, there is no
evidence that ATP acts directly on smooth muscle receptors
in the human ureter to cause a contraction, although very
high (0.1 mM) concentrations of ATP have been shown to
cause small contractions of the pig ureter [17]. Knight et al.
[16] demonstrated in the guinea-pig that the release of ATP
was abolished by removal of the urothelium and signifi-
cantly reduced by monensin, brefeldin A or calcium
depletion. Monensin is an inhibitor of vesicle formation
from the Golgi apparatus [18], and brefeldin A disrupts
vesicular trafficking by inhibiting protein transport from the
endoplasmic reticulum to the Golgi apparatus [19]. This
indicates that ATP is probably released from the urothelium
by vesicular exocytosis (a calcium-dependent process). The
release of ATP only occurred above a threshold of
approximately 25–30 cmH2O. This is similar to the ureteric
pressure threshold for pain measured by Risholm in 1954
[1]. He inserted ureteric catheters with an inflatable balloon
close to their tips into 69 women undergoing cystoscopy for
unrelated indications (using only urethral local anaesthetic
gel as analgesia). The balloons were inflated in various
Fig. 2 A plot of [ATP] measured in aliquots of perfusate taken
throughout a typical experiment with sequentially increasing ureteric
distension pressures
Fig. 3 [ATP] in perfusate immediately before and after distension
grouped in pressure ranges. The mean [ATP] after distension is
significantly greater than before distension in each pressure range
(**P <0.01; n≥7 for each group of distensions, error bars represent
SEM)
Fig. 1 Immunofluorescent staining of the suburothelial ureteric
nerves. a P2X3 receptor. b Capsaicin receptor (TRPV1). c P2X3
receptor pre-absorption control. d No primary antibody control. Scale
bar=50 μm for each figure. U urothelium, S submucosa, arrows
indicate suburothelial layer, arrowheads indicate sensory nerves
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pressures behind the obstructions were monitored. Inflation
of the balloon was generally not painful, but as normal
diuresis caused the pressures to gradually rise behind the
obstruction the patients experienced pain similar to renal
colic once a mean threshold of 33 mmHg (range: 21–
58 mmHg) was reached. This is also consistent with the
threshold for inducing a reflex fall in blood pressure in
spinally injured cats which was a ureteric pressure of 25–
30 mmHg [20]. Additionally, Sann and Cervero [21] found
that approximately half of the units in the guinea-pig
afferent ureteric nerves, which responded to ureteric
pressure changes, had a threshold of over 20 mmHg. It
was suggested that these nerves are more likely to conduct
pain messages, whilst the nerves with lower pressure
thresholds responded to the lower pressures generated by
normal peristalsis and may be involved in a peristalsis
feedback control mechanism. In the guinea-pig ureter
beyond the threshold pressure, ATP release was clearly
pressure dependent [16]. We found that although the mean
[ATP] in the perfusate was higher at higher pressures, the
differences were not statistically significant. There is
evidence from the rat bladder that in certain pathological
conditions, such as inflammation (interstitial cystitis), P2X3
receptors become sensitised and there is also a prominent
increase in the number of P2X3 receptor-positive neurons in
pelvic and lumbar splanchnic pathways, perhaps contribut-
ing to the hypersensitivity seen in pathophysiological
conditions [22]. Evidence for sensitization of P2X3 recep-
tors on sensory nerves of the human ureter remains to be
investigated.
The importance of purinergic mechanosensory transduc-
tion in the experience of ureteric pain in humans will
ultimately be determined by clinical trials of pharmacological
agents in patients with renal colic. We await the development
of a potent, selective P2X3 receptor antagonist that is
effective in vivo [23].
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